Assessment of post-operative nausea and vomiting prophylaxis usage for cesarean section, 2021: A cross sectional study.
Caesarean section
Nausea
Post-operative
Vomiting
antiemetics
prophylaxis
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
20
12
2021
revised:
11
02
2022
accepted:
21
02
2022
entrez:
7
4
2022
pubmed:
8
4
2022
medline:
8
4
2022
Statut:
epublish
Résumé
Post-operative nausea and vomiting (PONV) are common and distressing to patients. This common anesthetic and surgical side effect has been reported to increase patient dissatisfaction and can be more distressing to patients than post-operative pain. It has multi-factorial causes: patient, anesthesia and surgery related risk factors have been identified. Prevention of PONV is important since it has psychological and physical effects, and it can also cause severe complications. To determine the level of practice of PONV prophylaxis usage for caesarean section. This clinical perspective study was conducted at all pregnant mothers scheduled for caesarean section under anesthesia from March 1 to March 30, 2021 consecutively. The standards were directly changed into question forms with two integral checking components, "Yes", and "No". Data were entered and analyzed by statistical package of social sciences (SPSS) version 20. A total of 100 parturients scheduled for caesarean section were included with a response rate of 100%. Based on the standards, Anti-emetic treatment to patients with post-operative nausea and vomiting (PONV), adherence of anesthetists to local evidence based guideline for PONV prevention and more importantly no prophylactic administration to patients at low risk for PONV were implemented with a percentage of 17%,47%, and 14% respectively. and recommendations: There was a significant performance gap in the clinical practice of prevention of post-operative nausea and vomiting. We strongly suggest that adherence to a Protocol to reduce baseline risk and the adoption of a multimodal approach will highly likely ensure success in the management of PONV. The usage of appropriate anti-emetic prophylaxis to the right patient is necessary to have a good outcome after surgery and anesthesia.
Sections du résumé
Background
UNASSIGNED
Post-operative nausea and vomiting (PONV) are common and distressing to patients. This common anesthetic and surgical side effect has been reported to increase patient dissatisfaction and can be more distressing to patients than post-operative pain. It has multi-factorial causes: patient, anesthesia and surgery related risk factors have been identified. Prevention of PONV is important since it has psychological and physical effects, and it can also cause severe complications.
Objective
UNASSIGNED
To determine the level of practice of PONV prophylaxis usage for caesarean section.
Methods
UNASSIGNED
This clinical perspective study was conducted at all pregnant mothers scheduled for caesarean section under anesthesia from March 1 to March 30, 2021 consecutively. The standards were directly changed into question forms with two integral checking components, "Yes", and "No". Data were entered and analyzed by statistical package of social sciences (SPSS) version 20.
Results
UNASSIGNED
A total of 100 parturients scheduled for caesarean section were included with a response rate of 100%. Based on the standards, Anti-emetic treatment to patients with post-operative nausea and vomiting (PONV), adherence of anesthetists to local evidence based guideline for PONV prevention and more importantly no prophylactic administration to patients at low risk for PONV were implemented with a percentage of 17%,47%, and 14% respectively.
Conclusions
UNASSIGNED
and recommendations: There was a significant performance gap in the clinical practice of prevention of post-operative nausea and vomiting. We strongly suggest that adherence to a Protocol to reduce baseline risk and the adoption of a multimodal approach will highly likely ensure success in the management of PONV. The usage of appropriate anti-emetic prophylaxis to the right patient is necessary to have a good outcome after surgery and anesthesia.
Identifiants
pubmed: 35386765
doi: 10.1016/j.amsu.2022.103399
pii: S2049-0801(22)00159-5
pmc: PMC8977925
doi:
Types de publication
Journal Article
Langues
eng
Pagination
103399Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
There is no conflict of interest among the participants of the article.
Références
Pan Afr Med J. 2010;7:6
pubmed: 21954406
Anesthesiology. 2000 Apr;92(4):958-67
pubmed: 10754614
Int J Obstet Anesth. 2005 Jul;14(3):230-41
pubmed: 15935649
Int J Surg. 2021 Dec;96:106165
pubmed: 34774726
Anesth Analg. 1999 Sep;89(3):796-7
pubmed: 10475327
Anaesthesia. 2005 Apr;60(4):323-31
pubmed: 15766334
Anesthesiology. 1999 Sep;91(3):693-700
pubmed: 10485781
Anesthesiol Res Pract. 2011;2011:748031
pubmed: 22110499
Anaesthesia. 2003 Nov;58(11):1114-8
pubmed: 14616600
Korean J Anesthesiol. 2011 Jun;60(6):416-21
pubmed: 21738844
Gastroenterol Clin North Am. 1998 Mar;27(1):123-51
pubmed: 9546087
Br J Anaesth. 2012 Mar;108(3):423-9
pubmed: 22290456
J Family Med Prim Care. 2021 Feb;10(2):865-870
pubmed: 34041090
Anesth Analg. 2014 Jan;118(1):85-113
pubmed: 24356162
Reg Anesth. 1991 Mar-Apr;16(2):101-6
pubmed: 2043522
Eur J Anaesthesiol. 2012 Jan;29(1):57-9; author reply 59-60
pubmed: 21826006
Can J Anaesth. 1998 Jul;45(7):612-9
pubmed: 9717590
Eur J Anaesthesiol. 1993 May;10(3):175-81
pubmed: 8495679
Br J Anaesth. 2000 Apr;84(4):463-7
pubmed: 10823097
Anesthesiology. 2005 Jun;102(6):1094-100
pubmed: 15915019
Anaesthesia. 1997 May;52(5):443-9
pubmed: 9165963
Anesth Analg. 2020 Aug;131(2):411-448
pubmed: 32467512
J Obstet Gynaecol. 2006 Jul;26(5):433-4
pubmed: 16846870
Anesth Analg. 1984 Jan;63(1):85-7
pubmed: 6691570
Gastroenterol Clin North Am. 2003 Mar;32(1):201-34, vi
pubmed: 12635417
Nurs Stand. 2013 Jan 2-8;27(18):35-43
pubmed: 23431652
JAMA. 1989 Dec 1;262(21):3008-10
pubmed: 2810644